These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 10852302)

  • 1. Adverse reaction to Hylan GF-20.
    Allen E; Krohn K
    J Rheumatol; 2000 Jun; 27(6):1572. PubMed ID: 10852302
    [No Abstract]   [Full Text] [Related]  

  • 2. Bilateral symmetric inflammatory reaction to hylan G-F 20 injection.
    Martens PB
    Arthritis Rheum; 2001 Apr; 44(4):978-9. PubMed ID: 11315938
    [No Abstract]   [Full Text] [Related]  

  • 3. Synovial fluid findings in a patient after hylan GF 20 injection.
    Kwan-Morley J; Clayburne G; Schumacher HR
    J Clin Rheumatol; 2008 Apr; 14(2):120. PubMed ID: 18391685
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial.
    Jüni P; Reichenbach S; Trelle S; Tschannen B; Wandel S; Jordi B; Züllig M; Guetg R; Häuselmann HJ; Schwarz H; Theiler R; Ziswiler HR; Dieppe PA; Villiger PM; Egger M;
    Arthritis Rheum; 2007 Nov; 56(11):3610-9. PubMed ID: 17968921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee.
    Zardawi IM
    J Bone Joint Surg Am; 2003 Dec; 85(12):2484; author reply 2484-5. PubMed ID: 14668528
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute adverse reaction to hylan G-F 20: comment on the article by Martens.
    Tomás Gil J; Lopez Mateu P; Alegre J
    Arthritis Rheum; 2003 Mar; 48(3):866; author reply 866. PubMed ID: 12632457
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice.
    Kemper F; Gebhardt U; Meng T; Murray C
    Curr Med Res Opin; 2005 Aug; 21(8):1261-9. PubMed ID: 16083536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hylan G-F 20 tolerability with repeat treatment in a large orthopedic practice: a retrospective review.
    Waddell DD; Bricker DC
    J Surg Orthop Adv; 2006; 15(1):53-9. PubMed ID: 16603113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased frequency of acute local reaction to intra-articular hylan GF-20 (synvisc) in patients receiving more than one course of treatment.
    Leopold SS; Warme WJ; Pettis PD; Shott S
    J Bone Joint Surg Am; 2002 Sep; 84(9):1619-23. PubMed ID: 12208919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hylan and hyaluronic acid for knee osteoarthritis: comment on the article by Jüni et al.
    Chevalier X; Marini-Portugal A; Conrozier T
    Arthritis Rheum; 2008 May; 58(5):1560-1; author reply 1561-2. PubMed ID: 18438827
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee -- a prospective randomized clinical trial.
    Raman R; Dutta A; Day N; Sharma HK; Shaw CJ; Johnson GV
    Knee; 2008 Aug; 15(4):318-24. PubMed ID: 18430574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-articular hylan G-F 20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK).
    Clarke S; Lock V; Duddy J; Sharif M; Newman JH; Kirwan JR
    Knee; 2005 Jan; 12(1):57-62. PubMed ID: 15664879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
    Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
    Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term experience with hylan GF-20 in the treatment of knee osteoarthritis.
    Conrozier T; Chevalier X
    Expert Opin Pharmacother; 2008 Jul; 9(10):1797-804. PubMed ID: 18570611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review and meta-analysis of hylan versus hyaluronic acid: Comment on the article by Reichenbach et al.
    Marshall DC
    Arthritis Rheum; 2008 Sep; 59(9):1366; author reply 1366-7. PubMed ID: 18759311
    [No Abstract]   [Full Text] [Related]  

  • 16. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis.
    Waddell DD; Cefalu CA; Bricker DC
    Curr Med Res Opin; 2003; 19(6):499-507. PubMed ID: 14594522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee.
    Caborn D; Rush J; Lanzer W; Parenti D; Murray C;
    J Rheumatol; 2004 Feb; 31(2):333-43. PubMed ID: 14760806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of sodium hyaluronate and hylan G-F 20 in a clinical practice: comment on the concise communication by Martens.
    Brown DJ; Wood EV; Hannah HM; Rao VS; Teanby D
    Arthritis Rheum; 2004 May; 50(5):1697-8; author reply 1698. PubMed ID: 15146447
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictors of clinical response to intraarticular Hylan injections -- a prospective study using synovial fluid measures, clinical outcomes, and magnetic resonance imaging.
    Anandacoomarasamy A; Bagga H; Ding C; Burkhardt D; Sambrook PN; March LM
    J Rheumatol; 2008 Apr; 35(4):685-90. PubMed ID: 18278831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulomatous synovitis after intraarticular Hylan GF-20. A report of two cases.
    Michou L; Job-Deslandre C; de Pinieux G; Kahan A
    Joint Bone Spine; 2004 Sep; 71(5):438-40. PubMed ID: 15474399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.